Postoperative adjuvant therapy for resectable early non-small cell lung cancer: A protocol for a systematic review and meta-analysis

BACKGROUND: Lung cancer is one of the most common malignant tumors, and non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer diagnosed. For patients with resectable early stage non-small cell lung cancer, routine postoperative adjuvant therapy can significantly prolong overall pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Tianci, Zhang, Peipei, Lin, Yuhan, Zhang, Zhenyang, Lin, Wenwei, Kang, Mingqiang, Lin, Jiangbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709161/
https://www.ncbi.nlm.nih.gov/pubmed/31348250
http://dx.doi.org/10.1097/MD.0000000000016468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709161/
https://www.ncbi.nlm.nih.gov/pubmed/31348250
http://dx.doi.org/10.1097/MD.0000000000016468

Ejemplares similares